Skip to main content
SpringerLink
Log in

Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have shown that, within therapeutic plasma concentrations, the unbound fraction of furosemide changes in direct proportion to the reciprocal of the plasma albumin concentration (correlation coefficient 0.99). Changes in the albumin concentration were produced by ultrafiltration of human plasma using a haemofiltration filter. Thus, we propose that, when studying changes in the pharmacokinetics of a highly protein bound drug, calculated changes in the unbound fraction offer an alternative to actual measurement of the unbound concentration, which is often difficult.

Nine healthy volunteers receiving a continuous furosemide infusion were studied in normovolaemia and after dehydration (−1.4 kg), with and without pretreatment with an angiotensin converting enzyme inhibitor (captopril) or an a1-adrenoceptor blocking agent (prazosin). Significantly larger changes in the renal clearance of furosemide were found that could be explained by changes in the unbound fraction. Following dehydration, the unbound fraction of furosemide was decreased by about 5%, while its renal clearance fell by 27%, 33% and 13% after pretreatment with placebo, captopril and prazosin, respectively. The secretory clearance of the unbound furosemide changed substantially and in parallel with changes in the renal blood flow. It is suggested that changes in the renal clearance and excretion of furosemide and its t1/2 are much more dependent on changes in renal blood flow than on changes in its unbound fraction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andreasen F, Jakobsen P (1974) Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure. Acta Pharmacol Toxicol 35: 49–57

    Google Scholar 

  2. Odlind B, Beermann B (1980) Renal tubular secretion and effects of furosemide. Clin Pharmacol Ther 27: 784–790

    Google Scholar 

  3. Levy G (1980) Effect of plasma protein binding on renal clearance of drugs. J Pharm Sci 69: 482–483

    Google Scholar 

  4. Jansen JA (1981) Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and “well-stirred” model. J Pharmacokinet Biopharm 9: 15–26

    Google Scholar 

  5. Bowman RH (1975) Renal secretion [35S]furosemide and its depression by albumin binding. Am J Physiol 229: 93–98

    Google Scholar 

  6. Hall S, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263–268

    Google Scholar 

  7. Sjöström P, Odlind B, Beermann B, Hammarlund-Udenaes M (1988) On the mechanism of acute tolerance to furosemide diuresis. Scand J Urol Nephrol 22: 133–140

    Google Scholar 

  8. Führ J, Kaczmarczyk J, Krüttgen C-D (1955) Eine Einfache Colorimetrische Methode zur Inulinbestimmung für Nierenclearanceuntersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 33: 729–730

    Google Scholar 

  9. Brun C (1951) A rapid method for the determination of paraaminohippuric acid in kidney function test. J Lab Clin Med 37: 955–958

    Google Scholar 

  10. Hammarlund MM, Paalzow LK, Odlind B (1984) Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur J Clin Pharmacol 26: 197–207

    Google Scholar 

  11. Sjöström P, Odlind B, Beermann B, Hammarlund-Udenaes M (1987) Changes in furosemide pharmacokinetics induced by dehydration. In: Andreucci VE, Dal Canton A (eds) Diuretics: basic pharmacological and clinical aspects. Nijhoff, Dordrecht Boston, USA, pp 107–109

    Google Scholar 

  12. Lee L-J, Cook JA, Smith DE (1986) Renal transport kinetics of furosemide in the isolated perfused rat kidney. J Pharmacokinet Biopharm 14: 157–174

    Google Scholar 

  13. Sjöström P, Odlind B, Beermann B, Karlberg B (1989) Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. Eur J Clin Pharmacol 37: 173–180

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Örebro Medical Centre Hospital, Örebro, Sweden

    P. A. Sjöström & B. G. Kron

  2. Department of Medical Pharmacology, University of Uppsala, Uppsala, Sweden

    B. G. Odlind

Authors
  1. P. A. Sjöström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. G. Kron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. G. Odlind
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sjöström, P.A., Kron, B.G. & Odlind, B.G. Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration. Eur J Clin Pharmacol 45, 135–139 (1993). https://doi.org/10.1007/BF00315494

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315494

Key words

Search

Navigation